Table 2. . Patient demographics and clinical follow-up.

Patient	Age (years)	Sex	Site	Wide excision	Sentinel LN	Regional LND	Stage	Adjuvant therapy	Status	Follow-up (RFS)
1	14	Male	Extremity	Yes	No	No	II	No	Alive	24
2	6	Female	Extremity	Yes†	Yes(+)	Yes (-)	IIIA	No	Alive	17
3	16	Female	Extremity	Yes†	Yes (+)	Yes (-)	IIIIA	IFN × 2 yrs	Alive	27
4	10	Male	Extremity	Yes	Yes (+)	Yes (-)	IIIA	IFN × 1 year	Alive	34
5	2	Female	Head/neck	Yes†	Yes (+)	Yes (-)	IIIC	No	Alive	50
6	13	Male	Head/neck	Yes†	Yes (+)	Yes (+)‡	IIIC	IFN × 1 year, Local RT	Alive	34
7	4	Female	Head/neck	Yes	No	No	IIC	No	Alive	84
8	14	Male	Head/neck	Yes	Yes (+)	Yes (-)	III	IFN × 48 weeks	Alive	12
9	15	Male	Head/neck	Yes	Yes (-)	Yes (-)	III	No	Alive	84
10	12	Male	Head/neck	Yes	Yes (+)	Yes (+)	III	IFN	Alive	60

^†Patient 2, 3, 5 and 6 underwent a re-excision after partial resection.

^‡Patient 6 had multiple regional LN that were positive and had extra capsular local spread.

LN: Lymph node; LND: Lymph node dissection; RFS: Relapse-free survival; RT: Radiotherapy.